The brain tumor therapeutics market will register a CAGR of almost 12% by 2023

Thursday, June 13, 2019 General News
Email Print This Page Comment bookmark
Font : A-A+

NEW YORK, June 12, 2019 /PRNewswire/ -- About this marketThe rising prevalence of brain cancer is one of the key factors that will trigger the growth of the market. Most brain tumors are identified only in the late stages. The delay in diagnosis leads to the tumor becoming malignant. Also, factors such as cancer becoming metastasis are associated with the increasing prevalence

of brain cancer. Therefore, the morbid nature of the disease, increasing mortality rate and the huge unmet need caused by the rising prevalence of this disease is expected to increase the use of therapeutics for the treatment. Thus, such factors are expected to drive the growth of the market during the forecast period. Our analysts have predicted that the brain tumor therapeutics market will register a CAGR of almost 12% by 2023.Read the full report: https://www.reportlinker.com/p05778663/?utm_source=PRN Market OverviewStrategic alliancesThe market is expected to witness an increase in the number of strategic alliances between the universities and vendors, during the forecast period, thus adding significant growth to the global brain tumor therapeutics market.Preference for substitutesThe ease of treatment is expected to increase the demand for the alternating electric field therapy. This is expected to be a major challenge for the growth of the global brain tumor therapeutics market during the forecast period.For the detailed list of factors that will drive and challenge the growth of the brain tumor therapeutics market during 2019-2023, view our report.Competitive LandscapeThe market appears to be concentrated and with the presence of few companies including Bristol-Myers Squibb Co., and Eisai Co. Ltd., the competitive environment is quite intense. Several organizations are focusing on launching various products such as grey armbands, grey rings, and grey ribbon pins to promote the severity and awareness of brain cancer. The rising number of awareness campaigns is expected to result in the early diagnosis of the disease, thereby driving the market growth. This market research report will help clients identify new growth opportunities and design unique growth strategies by providing a comprehensive analysis of the market's competitive landscape and offering information on the products offered by companies.Read the full report: https://www.reportlinker.com/p05778663/?utm_source=PRN About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place. __________________________ Contact Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001

Cision View original content:http://www.prnewswire.com/news-releases/the-brain-tumor-therapeutics-market-will-register-a-cagr-of-almost-12-by-2023-300866845.html

SOURCE Reportlinker



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store